Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 254-075-1 | CAS number: 38668-48-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Diisopropanol-p-Toluidin was not sensitising in the guinea pig maximisation test.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11.09.2001-12.10.2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and OECD guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: MAFF Testing Guideline of 12 Nosan No. 1847
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- testing lab.
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Study was conducted before LLNA guideline was published.
- Species:
- guinea pig
- Strain:
- other: Hsd Poc: DH
- Sex:
- female
- Details on test animals and environmental conditions:
- The animals were identified via ear tattoo.
Age of the animals at start of the study: ca. 6 weeks
Body weight range at start of the study: 323 - 385 g
The guinea pigs were housed in fully air-conditioned rooms with a temperature in the range of 20 - 24°C
Relative humidity of 30 - 70 %
The day/night rhythm was 12 h dark and 12 h light
Five animals per cage (type stainless steel wire mesh cages with plastic-coated grating)
A standardized laboratory diet and tap water were available ad libitum
Source Harlan Winkelmann GmbH, Borchen, FRG - Route:
- intradermal and epicutaneous
- Vehicle:
- other: Lutrol E 400 or olive oil
- Concentration / amount:
- intradermal induction: 0.1 % in olive oil
epicutaneous induction: 50 % test substance preparation in Lutrol E 400
challenge: 25 % test substance preparation in Lutrol E 400 - Route:
- epicutaneous, occlusive
- Vehicle:
- other: Lutrol E 400 or olive oil
- Concentration / amount:
- intradermal induction: 0.1 % in olive oil
epicutaneous induction: 50 % test substance preparation in Lutrol E 400
challenge: 25 % test substance preparation in Lutrol E 400 - No. of animals per dose:
- 5 control group
10 test group - Details on study design:
- Induction
Intradermal induction:
6 intradermal injections in groups of two per animal were applied to each animal
side of application: neck region
Injections for the control groups:
A) front row: 2 injections each of 0.1 mL Freund's adjuvant without test substance
emulsified with 0.9 % aqueous NaCI-solution in a ratio of 1 : 1
B) middle row: 2 injections each of 0.1 mL of the undiluted vehicle
C) back row: 2 injections each of 0.1 mL of a 50 % formulation of the vehicle without
test substance emulsified with Freund's adjuvant* / 0.9 % aqueous NaCI-solution 1 :1
Injection for the test group:
A) front row: 2 injections each of 0.1 mL Freund's adjuvant* without test substance
emulsified with 0.9 % aqueous NaCI-solution in a ratio of 1 : 1
B) middle row: 2 injections each of 0.1 mL of a test substance formulation in an
appropriate vehicle at the selected concentration
C) back row: 2 injections each of 0.1 mL Freund's adjuvant* / 0.9 % aqueous
NaCI-solution 1 : 1 with test substance at the selected concentration.
Reading: 24 h after the beginning of application
Epicutaneous induction:
one week after intradermal induction
test group: 1 mL of the test substance formulation/animal
control group: treated analogously to the test group but only with the vehicle without the test substance
Duration of exposure: 48 hours
Side of application: neck region, same area as in the case of the previous intradermal application
Reading: 48 h after the beginning of application
Challenge:
14 days after the epicutaneous induction
0.5 mL of the test substance formulation was applied to each animal
test group and control group 1 were treated with the substance formulation. Additionally, Lutrol E 400 was applied as a vehicle control. Control group 2 only received Lutrol E 400.
Duration of exposure: 24 hours
Site of application: intact flank
Reading: 24 h and 48 h after the removal of the patch - Positive control substance(s):
- yes
- Remarks:
- A positive control with a known sensitizer was not included in this study. However, a separate study was performed twice a year in the Iaboratory using Alpha-Hexylcinnamaldehyde.
- Positive control results:
- The positive controls with Alpha-Hexylcinnamaldehyde techn. 85% showed that the test system was able to detect sensitizing compounds under the Iaboratory conditions chosen.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25 %
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Clinical observations:
- discrete or patchy erythema
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25 %. No with. + reactions: 1.0. Total no. in groups: 10.0. Clinical observations: discrete or patchy erythema.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Reference
The intradermal induction caused moderate and confluent erythema and swelling or intense erythema and swelling at the injection sites of the test substance preparation in all test group animals. After the epicutaneous induction incrustation, partially open (caused by the intradermal induction) could be observed in addition to moderate and confluent erythema and swelling in all test group animals.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a dermal sensitisation study with diisopropanol-p-toluidin (BASF AG, 2002) guinea pigs were tested using the maximisation test of Magnusson and Kligman according to the OECD Guideline 406. The test substance concentrations for the main test were selected based on the results of the pretest. The intradermal induction was performed with a 0.1 % test substance preparation in olive oil and the epicutaneous induction with a 50 % test substance preparation in Lutral® E 400. For the challenge a 25 % test substance preparation in Lutral® E 400 was chosen. The study was initiated with 2 control groups and 1 test group. The intradermal induction was performed on day 0 and the epicutaneous induction on day 7. A challenge was carried out 14 days after the epicutaneous induction. The intradermal induction caused moderate and confluent erythema and swelling or intense erythema and swelling at the injection sites of the test substance preparation in all test group animals. After the epicutaneous induction incrustation, partially open (caused by the intradermal induction) could be observed in addition to moderate and confluent erythema and swelling in all test group animals. After the challenge discrete or patchy erythema was observed in one out of 10 animal of the test group. Based on the results of this study it was concluded that diisopropanol-p-toluidin does not have a sensitising effect on the skin of the guinea pig in the maximization test under the test conditions chosen.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the available data, diisopropanol-p-toluidin is not subject to C&L according to Regulation 1272/2008/EC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.